FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200462703> ?p ?o ?g. }

• W4200462703 abstract "Abstract Context: The utility of phenobarbital in the treatment of severe alcohol withdrawal is contentious. Objective: The aim was to conduct a meta-analysis of existing observational and randomized controlled trials investigating the efficacy and safety of phenobarbital versus commonly used benzodiazepine in the setting of severe alcohol withdrawal. Data Sources: A search of PubMed, Medline, Embase, and the Cochrane Central Register of Controlled Trials published between 1976 and September 2021 was performed using medical subject headings: “severe alcohol withdrawal”, “delirium tremens” (DT), “phenobarbital” (PB), “barbiturate”, “critical care”, “ICU”, “Trial”, “human” and “English”. We selected English-language clinical trials (observational and randomized controlled trials (RCT)) evaluating the efficacy and safety of phenobarbital (PB) compared to benzodiazepine (BZD) for the treatment of severe alcohol withdrawal syndrome (AWS) in the acute care setting. Study Appraisal and synthesis methods: Data extraction and critical appraisal were carried out independently by two authors (EC and YM) using predefined data fields. The outcome variables analyzed included (a) history of DT; (b) initial CIWA-AR score; (c) drug dosages delivered; (d) duration of medical treatment of severe AWS; (e) other adjunct medication use; (f) intensive care unit (ICU) length of stay (LOS); (g) hospital LOS; (h) readmission rate; (i) DT or seizures; (j) other complications including endotracheal intubation and mechanical ventilation. These outcomes were unanimously decided to be important as they influence the practical management of severe AWS within hospitals and institutions. Heterogeneity amongst the outcome variables of these trials was determined by Cochran’s Q statistics and I² index. The meta-analysis was prepared in accordance with PRISMA guidelines. Results: Seven studies consisting of 1 prospective RCT and 6 retrospective trials were identified. Results from all the included studies show similar variables between BZD and PB group: mean age, percentage of patients with previous DT, and median Clinical Institute Withdrawal Assessment for Alcohol Revised (CIWA-AR) scores. There were no statistically significant differences in ICU and hospital LOS when comparing the BZD and PB groups. The prevalence of DT and adjunct medication usage was higher in the BZD group; however, statistically insignificant in the meta-analysis. The pooled prevalence of intubation was similar between the two treatment groups. Lastly, Hawa et al. reported higher alcohol-related re-admission in the BZD group. Conclusions: Based on our findings, the use of PB as the primary treatment, or when used in addition/as adjunct to BZD, offers several advantages in the treatment of severe AWS. These include trend toward improved DT and seizures in severe AWS, shortened ICU and hospital LOS, and less use of adjunct medications. Further RCTs are needed to investigate PB as the primary treatment of AWS that presents with severe features." @default.
• W4200462703 created "2021-12-31" @default.
• W4200462703 creator A5019121072 @default.
• W4200462703 creator A5052395182 @default.
• W4200462703 creator A5055179791 @default.
• W4200462703 creator A5059890725 @default.
• W4200462703 date "2021-12-13" @default.
• W4200462703 modified "2023-10-16" @default.
• W4200462703 title "Barbiturates Versus Benzodiazepine for the Treatment of Severe Alcohol Withdrawal Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials" @default.
• W4200462703 doi "https://doi.org/10.21203/rs.3.rs-1121796/v1" @default.
• W4200462703 hasPublicationYear "2021" @default.
• W4200462703 type Work @default.
• W4200462703 citedByCount "0" @default.
• W4200462703 crossrefType "posted-content" @default.
• W4200462703 hasAuthorship W4200462703A5019121072 @default.
• W4200462703 hasAuthorship W4200462703A5052395182 @default.
• W4200462703 hasAuthorship W4200462703A5055179791 @default.
• W4200462703 hasAuthorship W4200462703A5059890725 @default.
• W4200462703 hasBestOaLocation W42004627031 @default.
• W4200462703 hasConcept C126322002 @default.
• W4200462703 hasConcept C142724271 @default.
• W4200462703 hasConcept C151730666 @default.
• W4200462703 hasConcept C152541439 @default.
• W4200462703 hasConcept C168563851 @default.
• W4200462703 hasConcept C170493617 @default.
• W4200462703 hasConcept C177713679 @default.
• W4200462703 hasConcept C185592680 @default.
• W4200462703 hasConcept C194828623 @default.
• W4200462703 hasConcept C204787440 @default.
• W4200462703 hasConcept C23131810 @default.
• W4200462703 hasConcept C2776376669 @default.
• W4200462703 hasConcept C2776901510 @default.
• W4200462703 hasConcept C2778173252 @default.
• W4200462703 hasConcept C2778793413 @default.
• W4200462703 hasConcept C2779343474 @default.
• W4200462703 hasConcept C2780873584 @default.
• W4200462703 hasConcept C2781066024 @default.
• W4200462703 hasConcept C42219234 @default.
• W4200462703 hasConcept C535046627 @default.
• W4200462703 hasConcept C55493867 @default.
• W4200462703 hasConcept C71924100 @default.
• W4200462703 hasConcept C86803240 @default.
• W4200462703 hasConcept C95190672 @default.
• W4200462703 hasConceptScore W4200462703C126322002 @default.
• W4200462703 hasConceptScore W4200462703C142724271 @default.
• W4200462703 hasConceptScore W4200462703C151730666 @default.
• W4200462703 hasConceptScore W4200462703C152541439 @default.
• W4200462703 hasConceptScore W4200462703C168563851 @default.
• W4200462703 hasConceptScore W4200462703C170493617 @default.
• W4200462703 hasConceptScore W4200462703C177713679 @default.
• W4200462703 hasConceptScore W4200462703C185592680 @default.
• W4200462703 hasConceptScore W4200462703C194828623 @default.
• W4200462703 hasConceptScore W4200462703C204787440 @default.
• W4200462703 hasConceptScore W4200462703C23131810 @default.
• W4200462703 hasConceptScore W4200462703C2776376669 @default.
• W4200462703 hasConceptScore W4200462703C2776901510 @default.
• W4200462703 hasConceptScore W4200462703C2778173252 @default.
• W4200462703 hasConceptScore W4200462703C2778793413 @default.
• W4200462703 hasConceptScore W4200462703C2779343474 @default.
• W4200462703 hasConceptScore W4200462703C2780873584 @default.
• W4200462703 hasConceptScore W4200462703C2781066024 @default.
• W4200462703 hasConceptScore W4200462703C42219234 @default.
• W4200462703 hasConceptScore W4200462703C535046627 @default.
• W4200462703 hasConceptScore W4200462703C55493867 @default.
• W4200462703 hasConceptScore W4200462703C71924100 @default.
• W4200462703 hasConceptScore W4200462703C86803240 @default.
• W4200462703 hasConceptScore W4200462703C95190672 @default.
• W4200462703 hasLocation W42004627031 @default.
• W4200462703 hasOpenAccess W4200462703 @default.
• W4200462703 hasPrimaryLocation W42004627031 @default.
• W4200462703 hasRelatedWork W2056302709 @default.
• W4200462703 hasRelatedWork W2108670730 @default.
• W4200462703 hasRelatedWork W2761532342 @default.
• W4200462703 hasRelatedWork W2771036269 @default.
• W4200462703 hasRelatedWork W2911918021 @default.
• W4200462703 hasRelatedWork W3205656033 @default.
• W4200462703 hasRelatedWork W4200462703 @default.
• W4200462703 hasRelatedWork W4210272745 @default.
• W4200462703 hasRelatedWork W4238699343 @default.
• W4200462703 hasRelatedWork W4313267101 @default.
• W4200462703 isParatext "false" @default.
• W4200462703 isRetracted "false" @default.
• W4200462703 workType "article" @default.